NRX Pharmaceuticals Statistics
NASDAQ: NRXPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.15-0.40 (-15.69%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
NRX Pharmaceuticals by the numbers
NRX Pharmaceuticals has a market capitalization of $95.3 million based on 44.33M shares outstanding. With trailing EPS of $-0.33, NRX Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.0% below its 50-day average and 28.0% below its 200-day average.
Average daily trading volume is 1.07M shares, or about $2.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NRXP valuation vs. peer median
| Metric | NRXP | Peer median | Difference |
|---|---|---|---|
| Market cap | $95.31M | $95.83M | -1% |
| Avg. volume | 1.07M | 639.64K | +68% |
Peer median across 8 companies: PDSB, NBP, DERM, UNCY, CLLS, CNTN, CATX, NERV.
Valuation
- Market cap
- $95.31M
- Price / sales (latest FY)
- 77.80
- EPS (TTM)
- $-0.33
- Shares outstanding
- 44.33M
Price and trading
- Previous close
- 2.55
- Open
- 2.53
- Day range
- 2.14 – 2.53
- 52-week range
- 1.62 – 5.06
- 52-week change
- +0.94%
- Beta
- —
- Volume
- 1.47M
- Average volume
- 1.07M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 16, 2026
Additional statistics
- Market Cap
- 95.31M
- Forward Pe
- -6.14
- Eps
- -0.33
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.06
- Week52 Low
- 1.62
- Avg Volume
- 1.07M
- Shares Outstanding
- 44.33M
- Ma50
- 2.72
- Ma200
- 2.99
- Earnings Date
- Nov 16, 2026
- Pct From52w High
- -57.47%
- Pct From52w Low
- 32.72%